NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Trestle Biotherapeutics

Trestle Biotherapeutics

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://trestlebio.com/

Last Round

Grant

Jun 12, 2023

Est. Valuation

$1.79M

Total Funding Raised

$1.13M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Trestle Biotherapeutics is a biotechnology company that develops bioengineered kidney tissues to treat patients with end-stage renal disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, 3D Printing, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

regenerative medicine3d bioprintingbioprintinginduced pluripotent stem celliPSCkidney tissue engineeringorgan bioengineeringtissue engineeringend-stage renal diseasekidney disease therapybiofabricationbiotech startuporgan replacementlab-grown organs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Trestle Biotherapeutics Comparables

Compare Trestle Biotherapeutics with similar companies based on industry and business-model similarity.

Trestle Biotherapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Satellite Bio
82%
Rege Nephro Co., Ltd.
79%
LiveKidney.BIO
79%

Trestle Biotherapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 12, 2023
AcceleratorJan 5, 2021

Key People

Founding team and executive leadership

Ben Shepherd

Co-founder & CEO

Founding Team

Trestle Biotherapeutics Investors

Notable investors and investment history

Trestle Biotherapeutics investors
InvestorRounds
Y CombinatorAccelerator
Kidney Innovation AcceleratorGrant
C3 VenturesAccelerator
Black Mountain VenturesAccelerator
Formic VenturesAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 48% MoM.

  • Jan 5, 2021

    $125K raised in Seed round.

Trestle Biotherapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Trestle Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Trestle Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range6
Year Founded2020
Last FundingJun 12, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.